Patent · US Active

Secnidazole for use in the treatment of bacterial vaginosis

US11020377B2 · kind B2 · utility

1Cited by
41References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 27, 2019
Grant dateJun 1, 2021
Priority date—
Expiry dateSep 27, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.